Ergothioneine for Anti-Aging

Research suggests that ergothioneine may support healthy aging through multiple biological mechanisms, with a growing body of preclinical evidence showing lifespan extension in animal models, reductions in oxidative stress and neuroinflammation, improvements in cognitive function, and protective effects on skin and hair follicles against age-related changes. The available literature consists primarily of reviews, cell culture studies, and animal experiments — including mouse lifespan studies, D-galactose aging models, and C. elegans longevity assays — with several reviews noting ergothioneine's relevance to anti-aging pathways such as SIRT6 activation, glutathione recycling, and mitochondrial protection; the overall direction of this evidence is supportive, though one metabolomics study offered mixed findings by identifying declining ergothioneine levels as a marker of aging rather than a direct intervention outcome. Studies indicate that while the breadth of proposed mechanisms is notable — spanning antioxidant defense, anti-inflammatory signaling, neuroprotection, and cellular senescence reduction — the current evidence base is largely preclinical, with limited human clinical trial data to confirm whether these effects translate meaningfully to humans. Researchers and reviewers consistently acknowledge that questions around bioavailability, optimal intake, and long-term safety in humans remain insufficiently studied, and that further rigorous clinical investigation is needed before firm conclusions can be drawn about ergothioneine's role in human aging.